Schedule 13G ownership disclosure

Onconova Therapeutics Inc

Security class unavailable · CUSIP: 68232V306

Event date: 2019-09-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
206,730
Percent of class
2.5200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-19-000097
Form type
SC 13G
Filer
Traws Pharma, Inc.
CIK
CIK 1130598
Filed
Sep 27, 2019
Reporting period
Sep 23, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub